About ReForma
ReForma Therapeutics ™ is a privately held, development-stage pharmaceutical company focused on unlocking new value from proven medicines.
We identify opportunities where established therapies can be meaningfully improved through formulation innovation, advanced drug-delivery technologies and patient-centered product design.
Our development model combines established clinical knowledge with regulatory, technical and commercial expertise to create differentiated therapies with the potential for more efficient development and clearly defined pathways to partnership and value creation.
Our purpose is not to change a medicine for the sake of novelty. We pursue programs where product redesign has the potential to meaningfully address limitations in how a treatment is delivered, used or experienced with the goal of making treatment more practical for patients, caregivers and healthcare professionals.
Need-led development
We begin with a recognized treatment limitation and evaluate whether a new formulation, route of administration or delivery system can credibly address it.
Each option must fit the required dose and exposure profile, the intended user and treatment setting, the clinical and regulatory strategy, and the practical requirements of manufacturing and supply. It must also have the potential to create meaningful and defensible product differentiation.
Not every medicine is suited to every delivery route. Each route has practical limits on how much drug can be delivered and how quickly. We assess those limits early against the known dose and exposure requirements of the medicine, allowing us to rule out approaches that are not technically feasible and focus development on those that are.
Programs
Every ReForma program is built around series of factors; a defined unmet need; an established active ingredient; a differentiated product concept; a product-specific regulatory strategy; early identification of technical and development risk; clear decision criteria and defined milestones; and a credible route to partnership or commercialization.
This disciplined approach enables us to build a portfolio of programs rather than rely on a single asset or technology.
Senior-led and partner-enabled
Core scientific, regulatory, CMC, device, commercial and operational decision-making remains within ReForma. Specialized development and execution are carried out with selected formulation, device, manufacturing, clinical and advisory partners.
This model gives ReForma access to specialized expertise and capabilities while maintaining internal oversight of program strategy, governance, key development decisions and capital allocation.
ReForma operates through a leadership team based across the United States and United Kingdom, supported by a global network of specialized development partners.
We determine the appropriate development and regulatory strategy for each program and target market.
“Transforming Treatments, Empowering Lives”
We turn proven medicines into better treatment experiences for patients worldwide.
Our vision
To identify meaningful limitations in established therapies and address them through innovative formulation, drug-delivery technology and patient-centered product design. By integrating scientific, regulatory and commercial expertise, we aim to advance differentiated medicines efficiently and create lasting value for patients, healthcare systems and our partners